series-c-plus
Stage
2009
Founded
1
Investors
About
Adrenomed is a clinical-stage biopharmaceutical company based in Germany. It develops novel therapies, including its lead product Adrecizumab, for life-threatening conditions like septic shock.
Explore Adrenomed's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.